stoxline Quote Chart Rank Option Currency Glossary
  
Haemonetics Corporation (HAE)
85.35  1.26 (1.5%)    03-28 16:00
Open: 83.92
High: 85.44
Volume: 593,876
  
Pre. Close: 84.09
Low: 83.67
Market Cap: 4,335(M)
Technical analysis
2024-03-28 4:51:52 PM
Short term     
Mid term     
Targets 6-month :  99.79 1-year :  116.55
Resists First :  85.44 Second :  99.79
Pivot price 79.21
Supports First :  77.13 Second :  72
MAs MA(5) :  82.63 MA(20) :  78.44
MA(100) :  81.21 MA(250) :  84.73
MACD MACD :  1.8 Signal :  0.8
%K %D K(14,3) :  96.5 D(3) :  94.6
RSI RSI(14): 72.1
52-week High :  95.26 Low :  70.73
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ HAE ] has closed above the upper band by 0.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 42.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 85.55 - 85.9 85.9 - 86.23
Low: 82.81 - 83.19 83.19 - 83.56
Close: 84.73 - 85.34 85.34 - 85.91
Company Description

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Headline News

Mon, 25 Mar 2024
Is Haemonetics Corporation's (NYSE:HAE) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - Simply Wall St

Sun, 24 Mar 2024
Why Is Haemonetics (HAE) Down 1.4% Since Last Earnings Report? - Yahoo Movies UK

Sun, 24 Mar 2024
Here's Why Haemonetics (HAE) is a Great Momentum Stock to Buy - Yahoo Movies UK

Thu, 07 Mar 2024
Haemonetics Corporation (NYSE:HAE) Shares Could Be 35% Below Their Intrinsic Value Estimate - Simply Wall St

Thu, 07 Mar 2024
Haemonetics Corporation (NYSE:HAE) Shares Could Be 35% Below Their Intrinsic Value Estimate - Yahoo Finance

Wed, 06 Mar 2024
Haemonetics - Improved Performance, Another Bolt-On Deal (NYSE:HAE) - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 51 (M)
Shares Float 50 (M)
Held by Insiders 0.7 (%)
Held by Institutions 101 (%)
Shares Short 1,960 (K)
Shares Short P.Month 1,670 (K)
Stock Financials
EPS 2.46
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 18.57
Profit Margin 9.9 %
Operating Margin 16 %
Return on Assets (ttm) 6.1 %
Return on Equity (ttm) 14.7 %
Qtrly Rev. Growth 10.1 %
Gross Profit (p.s.) 0
Sales Per Share 25
EBITDA (p.s.) 5.77
Qtrly Earnings Growth -4.7 %
Operating Cash Flow 197 (M)
Levered Free Cash Flow 117 (M)
Stock Valuations
PE Ratio 34.69
PEG Ratio 1.6
Price to Book value 4.59
Price to Sales 3.41
Price to Cash Flow 21.97
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android